Cost-effectiveness Analysis of Xueshuantong Injection (Lyophilized) in the Treatment of Acute Ischemic Stroke with Qi Stagnation and Blood Stasis Syndrome Based on Decision Tree Model

Cui Xin, Geng Hongjiao, Han Sheng, Xie Yanming

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (8) : 905-912.

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (8) : 905-912. DOI: 10.16153/j.1002-7777.2023.08.007
Supervision Administration

Cost-effectiveness Analysis of Xueshuantong Injection (Lyophilized) in the Treatment of Acute Ischemic Stroke with Qi Stagnation and Blood Stasis Syndrome Based on Decision Tree Model

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 37(8): 905-912 https://doi.org/10.16153/j.1002-7777.2023.08.007

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/